A citation-based method for searching scientific literature

Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli, Jessica Read, Peter Langmuir, Anderson J Ryan, Martin J Schlumberger. J Clin Oncol 2012
Times Cited: 839



Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini, Friedhelm Raue, Karin Frank-Raue, Bruce Robinson, M Sara Rosenthal, Massimo Santoro, Martin Schlumberger, Manisha Shah, Steven G Waguespack. Thyroid 2015
Times Cited: 912




List of shared articles



Times cited

Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, Gilda Varricchi, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Salvatore Benvenga, Alessandro Antonelli. Semin Cancer Biol 2022
20

State of the art and future directions in the systemic treatment of medullary thyroid cancer.
Eline C Jager, K Esther Broekman, Schelto Kruijff, Thera P Links. Curr Opin Oncol 2022
1

Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series.
Viktoria F Koehler, Carmina T Fuss, Christina M Berr, Karin Frank-Raue, Friedhelm Raue, Eva Hoster, Matthias Hepprich, Emanuel Christ, Thomas Pusl, Martin Reincke,[...]. Clin Endocrinol (Oxf) 2022
1

Updates on therapy for medullary thyroid cancer in 2021.
Marie Puerto, Françoise Borson-Chazot, Antoine Tabarin. Ann Endocrinol (Paris) 2022
1

Surgical aspects and controversies in the management of medullary thyroid cancer.
Katerina Green, Justin Hintze, James Paul O'Neill. Ir J Med Sci 2022
0

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
Lucy X Ma, Osvaldo Espin-Garcia, Philippe L Bedard, Tracy Stockley, Rebecca Prince, Ozgur Mete, Monika K Krzyzanowska. Thyroid 2022
0

Molecular Imaging and Theragnostics of Thyroid Cancers.
Luca Giovanella, Desiree' Deandreis, Alexis Vrachimis, Alfredo Campenni, Petra Petranovic Ovcaricek. Cancers (Basel) 2022
0

Medullary thyroid cancer - An update.
Laura Fugazzola. Best Pract Res Clin Endocrinol Metab 2022
0

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma.
Ai Matsui, Soji Toda, Daisuke Murayama, Hiroyuki Iwasaki. Case Rep Endocrinol 2022
0

An Audit of Systemic Therapy in Medullary Carcinoma Thyroid.
Aditya Pavan Kumar Kanteti, George Abraham, Vijay M Patil, Nandini Menon, Tanmoy Mandal, Sobin V Jacob, Keshav Garg, Anbarasan Sekar, Rup Jyoti Sarma, Laxma Reddy Mekala,[...]. Indian J Surg Oncol 2022
0


Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer.
Evan Walgama, Naifa Busaidy, Mark Zafereo. Endocrinol Metab Clin North Am 2022
0

Multiple endocrine neoplasia type 2: A review.
Jes Sloth Mathiesen, Grigoris Effraimidis, Maria Rossing, Åse Krogh Rasmussen, Lise Hoejberg, Lars Bastholt, Christian Godballe, Peter Oturai, Ulla Feldt-Rasmussen. Semin Cancer Biol 2022
5

Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy.
Nicholas L Kesby, Alexander J Papachristos, Matti Gild, Ahmad Aniss, Mark S Sywak, Roderick Clifton-Bligh, Stan B Sidhu, Anthony R Glover. Ann Surg Oncol 2022
2

Multiple endocrine neoplasia 2: an overview.
B Saravana-Bawan, J D Pasternak. Ther Adv Chronic Dis 2022
0

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa. Cancer Treat Rev 2022
0

American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
David C Shonka, Alan Ho, Ashish V Chintakuntlawar, Jessica L Geiger, Jong C Park, Nagashree Seetharamu, Sina Jasim, Amr H Abdelhamid Ahmed, Keith C Bible, Marcia S Brose,[...]. Head Neck 2022
1

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.
Antonio Matrone, Carla Gambale, Alessandro Prete, Rossella Elisei. Front Endocrinol (Lausanne) 2022
1

Thyroid Dysfunction from Treatments for Solid Organ Cancers.
Anupam Kotwal, Donald S A McLeod. Endocrinol Metab Clin North Am 2022
0

Impact of multikinase inhibitor approval on survival and physician practice patterns in advanced or metastatic medullary thyroid carcinoma.
Jessica W Thiesmeyer, Jessica Limberg, Timothy M Ullmann, Dessislava Stefanova, Sarina Bains, Toni Beninato, Rasa Zarnegar, Thomas J Fahey, Brendan M Finnerty. Surgery 2021
1

Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model.
Silvia Carra, Germano Gaudenzi, Alessandra Dicitore, Davide Saronni, Maria Celeste Cantone, Alice Plebani, Anna Ghilardi, Maria Orietta Borghi, Leo J Hofland, Luca Persani,[...]. Int J Mol Sci 2021
0

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
Carrie C Lubitz, Peter M Sadow, Gilbert H Daniels, Lori J Wirth. Thyroid 2021
5

Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Charalampos Aktypis, Maria-Eleni Spei, Maria Yavropoulou, Göran Wallin, Anna Koumarianou, Gregory Kaltsas, Eva Kassi, Kosmas Daskalakis. Cancers (Basel) 2021
2

Benefits and Limitations of TKIs in Patients with Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis.
Zoe A Efstathiadou, Charalambos Tsentidis, Alexandra Bargiota, Vasiliki Daraki, Kalliopi Kotsa, Georgia Ntali, Labrini Papanastasiou, Stelios Tigas, Konstantinos Toulis, Kalliopi Pazaitou-Panayiotou,[...]. Eur Thyroid J 2021
4

Current Guidelines for Management of Medullary Thyroid Carcinoma.
Mijin Kim, Bo Hyun Kim. Endocrinol Metab (Seoul) 2021
2

Translational Utility of Liquid Biopsies in Thyroid Cancer Management.
Ayanthi A Wijewardene, Marthe Chehade, Matti L Gild, Roderick J Clifton-Bligh, Martyn Bullock. Cancers (Basel) 2021
0

Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
Aimee R Hayes, Alexander Crawford, Khulood Al Riyami, Christine Tang, Jamshed Bomanji, Stephanie E Baldeweg, Damian Wild, Daniel Morganstein, Alice Harry, Simona Grozinsky-Glasberg,[...]. J Clin Endocrinol Metab 2021
4

Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett. J Med Chem 2021
1

Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.
Felix Eckelt, Roland Pfaeffle, Wieland Kiess, Juergen Kratzsch. J Pediatr Endocrinol Metab 2021
0

[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network].
Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, Stéphane Bardet, Abir Al Ghuzlan, Isabelle Borget, Françoise Borson Chazot, Christine Do Cao, Camille Buffet, Slimane Zerdoud,[...]. Bull Cancer 2021
0

Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
Tim Brandenburg, Vera Tiedje, Philipp Muchalla, Sarah Theurer, Frank Weber, Kurt Werner Schmid, Henning Dralle, Dagmar Führer. Front Endocrinol (Lausanne) 2021
0

Immune Profiling of Medullary Thyroid Cancer-An Opportunity for Immunotherapy.
Kinga Hińcza-Nowak, Artur Kowalik, Agnieszka Walczyk, Iwona Pałyga, Danuta Gąsior-Perczak, Agnieszka Płusa, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź, Aldona Kowalska. Genes (Basel) 2021
0